Manufacture

Analytical QbD (AQbD) promises to extend the rigor and benefits of QbD into the area of analytical method development.

Sitting Down With... Dirk Sauer, Novartis’ Global Head, Development Franchise Ophthalmics.

Will bacteriophages be the savior of the human race in the post-antibiotic era or is it just pie in the sky?

By mimicking natural evolution of enzymes, researchers are creating biocatalysts for reactions unheard of in nature.

But can pharma manufacturers do more to help prevent medication errors?

What impact will genetic changes have on new medicines currently in development?

By eliminating protein A, researchers aim to deliver continuous processing at a fraction of the cost of conventional techniques.

We speak to Professor Begoña Calvo to find out more about her research into pharmaco vigilance for biosimilars.

The first US biosimilar has been pocketed and the game is on. We bring six experts to the table to discuss the impact on industry dynamics.

The industry has been dipping its toe into the water of continuous manufacturing for years.